MDA-MB-436 Cells
USD 450.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Información general
| Descripción | The MDA-MB-436 cell line is derived from a human breast adenocarcinoma. This cell line is characterized by its triple-negative breast cancer (TNBC) phenotype, lacking estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. Such characteristics make it an invaluable model for studying TNBC, a particularly aggressive and difficult-to-treat subtype of breast cancer. The cells exhibit an epithelial morphology and are known for their robust proliferative capacity in vitro. Genetically, MDA-MB-436 cells harbor mutations in key cancer-related genes, including BRCA1 and TP53. The BRCA1 mutation is of particular interest, as it mirrors the genetic alterations found in a subset of hereditary breast cancers. This makes MDA-MB-436 a crucial tool for investigating the mechanisms underlying BRCA1-associated tumorigenesis and for testing potential therapeutic strategies targeting these pathways. Additionally, the cell line has been employed in research focused on chemotherapy resistance, metastasis, and the tumor microenvironment. Researchers working with MDA-MB-436 cells benefit from its well-documented characteristics, allowing for reproducible and reliable experimental outcomes. Studies utilizing this cell line contribute significantly to the understanding of TNBC biology and the development of novel treatments for this challenging cancer subtype. However, care must be taken in experimental design, as the absence of hormone receptors and HER2 expression necessitates alternative approaches compared to other breast cancer models. |
|---|---|
| Organismo | Human |
| Tejido | Breast |
| Enfermedad | Carcinoma |
| Lugar de metástasis | Pleural effusion |
| Sinónimos | MDA_MB_436, MDA MB 436, MDA-Mb-436, MDA-MB436, MDAMB436, MDA-436, MDA436, MB436, MD Anderson-Metastatic Breast-436 |
Características
| Edad | 43 years |
|---|---|
| Género | Female |
| Origen étnico | European |
| Morfología | Pleomorphic and multinucleated cells |
| Propiedades de crecimiento | Adherent |
Datos normativos
| Referencia | MDA-MB-436 (Cytion catalog number 300278) |
|---|---|
| Nivel de bioseguridad | 1 |
| NCBI_TaxID | 9606 |
| N.º de acceso de Cellosaurus | CVCL_0623 |
Datos biomoleculares
Manejo
| Medio de cultivo | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Suplementos | Supplement the medium with 5% FBS |
| Reactivo de disociación | Accutase |
| Subcultivo | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Renovación de fluidos | 2 to 3 times per week |
| Medio de congelación | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelación y cultivo de células |
|
| Atmósfera de incubación | 37°C, 5% CO2, humidified atmosphere. |
| Condiciones de envío | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condiciones de almacenamiento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Control de calidad y análisis molecular
| Esterilidad | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de análisis (CoA)
| Número de lote | Tipo de certificado | Fecha | Número de catálogo |
|---|---|---|---|
| 300278-712 | Certificado de análisis | 23. May. 2025 | 300278 |
| 300278-210325 | Certificado de análisis | 23. May. 2025 | 300278 |
-
Related products
Related products
Células MDA-MB-361Organismo Humano Tejido Senos, glándula mamaria Enfermedad Adenocarcinoma USD 395.00*MDA-MB-175-VII CellsOrganismo Human Tejido Metastatic Enfermedad Invasive breast carcinoma of no special type USD 550.00*